Literature DB >> 7494400

Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation.

E G Shapiro1, L A Lockman, M Balthazor, W Krivit.   

Abstract

Neuropsychological assessment is essential in providing documentation of the untreated natural history of storage diseases associated with dementia and quantifying the effectiveness of treatment on central nervous system function. Baseline characterization and outcome of bone marrow transplantation (BMT) for three leukodystrophies and three mucopolysaccharidoses are presented. Results suggests that BMT for Hurler syndrome, adrenoleukodystrophy, and globoid cell leukodystrophy can be effective in preventing dementia if done early enough in the disease. Sanfilippo and Hunter syndromes do not benefit and BMT is not recommended. For metachromatic leukodystrophy, BMT is not recommended for symptomatic early-onset forms of the disease. Further longitudinal follow-up is needed to determine whether the benefits outweigh the risks of BMT for late-onset and preclinical metachromatic leukodystrophy.

Entities:  

Mesh:

Year:  1995        PMID: 7494400     DOI: 10.1007/bf00710053

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  7 in total

1.  Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation.

Authors:  W Krivit; E Shapiro; W Kennedy; M Lipton; L Lockman; S Smith; C G Summers; D A Wenger; M Y Tsai; N K Ramsay
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

2.  Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation.

Authors:  G Pridjian; J Humbert; J Willis; E Shapira
Journal:  J Pediatr       Date:  1994-11       Impact factor: 4.406

3.  Long-term outcome of Hurler syndrome following bone marrow transplantation.

Authors:  C B Whitley; K G Belani; P N Chang; C G Summers; B R Blazar; M Y Tsai; R E Latchaw; N K Ramsay; J H Kersey
Journal:  Am J Med Genet       Date:  1993-04-15

4.  White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplant.

Authors:  E G Shapiro; M E Lipton; W Krivit
Journal:  J Clin Exp Neuropsychol       Date:  1992-07       Impact factor: 2.475

Review 5.  Adrenoleukodystrophy: phenotypic variability and implications for therapy.

Authors:  H W Moser; A B Moser; K D Smith; A Bergin; J Borel; J Shankroff; O C Stine; C Merette; J Ott; W Krivit
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Characteristics of the dementia in late-onset metachromatic leukodystrophy.

Authors:  E G Shapiro; L A Lockman; D Knopman; W Krivit
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

7.  Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations.

Authors:  D J Loes; A E Stillman; S Hite; E Shapiro; L Lockman; R E Latchaw; H Moser; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

  7 in total
  58 in total

Review 1.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 2.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 3.  Research challenges in central nervous system manifestations of inborn errors of metabolism.

Authors:  P I Dickson; A R Pariser; S C Groft; R W Ishihara; D E McNeil; D Tagle; D J Griebel; S G Kaler; J W Mink; E G Shapiro; K J Bjoraker; L Krivitzky; J M Provenzale; A Gropman; P Orchard; G Raymond; B H Cohen; R D Steiner; S F Goldkind; R M Nelson; E Kakkis; M C Patterson
Journal:  Mol Genet Metab       Date:  2010-12-02       Impact factor: 4.797

Review 4.  Diagnostic work-up of a peroxisomal patient.

Authors:  J G Leroy; M Espeel; J F Gadisseux; H Mandel; M Martinez; B T Poll-The; R J Wanders; F Roels
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Neonatal Bone Marrow Transplantation in MPS IIIA Mice.

Authors:  Adeline A Lau; N Jannah Shamsani; Leanne K Winner; Sofia Hassiotis; Barbara M King; John J Hopwood; Kim M Hemsley
Journal:  JIMD Rep       Date:  2012-08-10

Review 6.  Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.

Authors:  Adeline A Lau; Kim M Hemsley
Journal:  J Mol Med (Berl)       Date:  2017-06-29       Impact factor: 4.599

7.  Early Umbilical Cord Blood-Derived Stem Cell Transplantation Does Not Prevent Neurological Deterioration in Mucopolysaccharidosis Type III.

Authors:  Lindsey Welling; Jan Pieter Marchal; Peter van Hasselt; Ans T van der Ploeg; Frits A Wijburg; Jaap Jan Boelens
Journal:  JIMD Rep       Date:  2014-09-26

8.  Review of the use of idursulfase in the treatment of mucopolysaccharidosis II.

Authors:  T Andrew Burrow; Nancy D Leslie
Journal:  Biologics       Date:  2008-06

9.  Longitudinal neurocognitive outcome in an adolescent with Hurler-Scheie syndrome.

Authors:  T David Elkin; Gail Megason; Anita Robinson; Hans-Georg O Bock; Gregory Schrimsher; Joseph Muenzer
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

10.  alpha-L-iduronidase therapy for mucopolysaccharidosis type I.

Authors:  Jakub Tolar; Paul J Orchard
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.